Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.2K
Tumor Progression02:07

Tumor Progression

6.9K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.9K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

1.4K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.4K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.1K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.1K
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

2.2K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.2K
Amyloid Fibrils03:03

Amyloid Fibrils

11.1K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

WWOX contributes to DNA damage, but not somatic instability in Huntington's disease.

bioRxiv : the preprint server for biology·2026
Same author

TRACE: Open-source software for quantifying somatic variation of tandem repeats by capillary electrophoresis.

Journal of Huntington's disease·2026
Same author

Expanding repeats, expanding impact: Somatic instability in myotonic dystrophy type 1.

Journal of neuromuscular diseases·2026
Same author

Whole-Exome Sequencing Improves Risk Assessments of Adult Moyamoya Disease.

Journal of clinical neurology (Seoul, Korea)·2026
Same author

Huntington's disease LIG1 modifier variant increases ligase fidelity and suppresses somatic CAG repeat expansion.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

TRACE: Open-Source Software for Quantifying Somatic Variation of Tandem Repeats by Capillary Electrophoresis.

bioRxiv : the preprint server for biology·2026
Same journal

Phase-targeted auditory stimulation enhances slow-wave activity during sleep in Huntington's disease: A pilot crossover study.

Journal of Huntington's disease·2026
Same journal

Differential sensitivity of the MMSE and MoCA for staging and longitudinal cognitive change in Huntington's disease.

Journal of Huntington's disease·2026
Same journal

Clinical implications of loss of interruption variants for diagnosis, genetic counselling, and clinical trials in Huntington's disease.

Journal of Huntington's disease·2026
Same journal

Preface to special issue on neurodevelopment in Huntington's disease.

Journal of Huntington's disease·2026
Same journal

The sparse evidence-base for self-injurious behavior in Huntington's disease: A call to action.

Journal of Huntington's disease·2026
Same journal

The holistic burden of Huntington's disease: A qualitative study of multigenerational impact on individuals and family caregivers across Europe.

Journal of Huntington's disease·2026
See all related articles

Related Experiment Video

Updated: Nov 17, 2025

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
07:08

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

9.9K

Huntington's Disease Pathogenesis: Two Sequential Components.

Eun Pyo Hong1,2,3, Marcy E MacDonald1,2,3, Vanessa C Wheeler1,2

  • 1Molecular Neurogenetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.

Journal of Huntington'S Disease
|February 13, 2021
PubMed
Summary
This summary is machine-generated.

Huntington's disease (HD) research advanced human genetics, leading to the HTT gene discovery. Genetic analysis of HD offers insights into its two-stage pathogenesis, though effective treatments remain elusive.

Keywords:
Huntington diseasegenetic associationgeneticsgenotype-phenotype correlationmodifier genetrinucleotide repeat expansion

More Related Videos

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
10:52

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

2.8K
Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
11:22

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Published on: June 27, 2018

8.3K

Related Experiment Videos

Last Updated: Nov 17, 2025

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
07:08

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

9.9K
Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
10:52

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

2.8K
Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
11:22

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Published on: June 27, 2018

8.3K

Area of Science:

  • Human Genetics
  • Neurodegenerative Disorders
  • Genomic Medicine

Background:

  • Huntington's disease (HD) is a familial neurodegenerative disorder characterized by motor, cognitive, and psychiatric symptoms.
  • HD's genetic basis was the first autosomal disease mapped using DNA polymorphisms, significantly impacting human genetics research.
  • The identification of the HD gene (HTT) and its location spurred technological advancements crucial for the Human Genome Project.

Purpose of the Study:

  • To highlight the historical significance of Huntington's disease in advancing human genetics.
  • To underscore the role of HD genetic research in developing gene cloning and sequencing technologies.
  • To explain how genotype-phenotype studies in HD provide insights into disease mechanisms.

Main Methods:

  • Genetic linkage analysis with DNA polymorphisms to map the HD gene.
  • Gene cloning and sequencing technologies developed using the HTT locus as a model.
  • Genotype-phenotype relationship analysis in large Huntington's disease patient cohorts.

Main Results:

  • The genetic defect for Huntington's disease was localized to chromosome 4p16.3, identifying the HTT gene.
  • Advancements in genetic technologies were accelerated by research on the HD gene.
  • Analysis of HD patient data revealed genotype-phenotype correlations, elucidating disease pathogenesis.

Conclusions:

  • The study of Huntington's disease has been pivotal in the progress of human genetics and genomic technologies.
  • Despite the identification of the HTT gene, effective treatments for HD are still under development.
  • Ongoing genetic research continues to deepen our understanding of HD pathogenesis, distinguishing distinct disease phases.